The global race for a T cell receptor that zeros in on—and annihilates—solid tumors
Italy finally meets 500,000 daily vaccinations target
30 April 2021After 47 minutes, one final try resuscitated her
30 April 2021The global race for a T cell receptor that zeros in on—and annihilates—solid tumors
Immunobiologists in China have designed a synthetic T cell receptor for anticancer therapy, engineering the protein not only with a capability to seek and destroy solid tumors, but endowing this cancer fighting weapon with potent endurance to get the job done.
